88 related articles for article (PubMed ID: 4476537)
1. [Proceedings: Clinical experience with administration of 2 alpha, 3 alpha- epithio-5 alpha-androstan-17 beta- yl, 1-methoxy-cyclopentyl ether (10364-S) in breast diseases].
Izuo M; Okada T; Suemasu K; Fujimori M
Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):509. PubMed ID: 4476537
[No Abstract] [Full Text] [Related]
2. [Proceedings: Clinical evaluation of a new protein anabolic steroid, 2 alpha-3 alpha-epithio-5 alpha-androstan-17 beta-yl, 1, -methoxycyxlopentyl ether (10364-S)].
Iwai K; Honda H; Yamada S; Fukase M
Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):501. PubMed ID: 4476529
[No Abstract] [Full Text] [Related]
3. [Proceedings: Anti-estrogen action of 2 alpha, 3 alpha-epithio-5 alpha-androstan-17 beta-yl, 1-methoxy-cyclopentyl ether (10364-S)].
Miyake T; Hori T; Ide M
Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):511. PubMed ID: 4476538
[No Abstract] [Full Text] [Related]
4. 2alpha, 3alpha-epithio-5alpha-androstan-17beta-yl 1-methoxycyclopentyl ether in the treatment of advanced breast cancer: Japanese Cooperative Group of Hormonal Treatment for Breast Cancer.
Cancer; 1978 Feb; 41(2):758-60. PubMed ID: 343913
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of mepitiostane on the growth of mammary tumor of a rat.
Takatani O; Kumaoka S
Gan; 1977 Jun; 68(3):337-41. PubMed ID: 913955
[TBL] [Abstract][Full Text] [Related]
6. Proceedings: 2 alpha, 3 alpha-epithio-5alpha-androstan-17beta-YL 1-methoxy-cyclophenyl ether (10364-S), a new orally active anabolic-androgenic steroid.
Miyake T; Uchida K; Kakushi H; Nomura Y; Kadowaki M
Jpn J Pharmacol; 1974; 24(0):s:130. PubMed ID: 4545688
[No Abstract] [Full Text] [Related]
7. 2 alpha, 3 alpha-epithio-5 alpha-androstan-17 beta-OL in the treatment of chronic mastopathy.
Izuo M; Fujimori M
Endocrinol Jpn; 1968 Sep; 15(3):371-4. PubMed ID: 4237209
[No Abstract] [Full Text] [Related]
8. Effects of 2alpha, 3alpha-epithio-5alpha-androstan-17beta-ol (epitiostanol) on hypothalamo-pituitary-gonadal axis in humans.
Kurachi K; Aono T; Tomoyama J; Matsumoto K; Nakasima A
Acta Obstet Gynaecol Jpn; 1975 Jan; 22(1):42-8. PubMed ID: 1224948
[No Abstract] [Full Text] [Related]
9. 2alpha, 3alpha-epithio-5alpha-androstan-17beta-yl 1-methoxycyclopentyl ether (10361-S), a new orally active anabolic-androgenic steroid.
Miyake T; Uchida K; Kakushi H; Nomura Y; Kadowaki M
Jpn J Pharmacol; 1974 Aug; 24(4):551-8. PubMed ID: 4455965
[No Abstract] [Full Text] [Related]
10. 2 ,3 - Epithio-5 -androstan-17 -ol in the treatment of advanced breast cancer.
Fujimori M
Cancer; 1973 Apr; 31(4):789-92. PubMed ID: 4574661
[No Abstract] [Full Text] [Related]
11. [Clinical experiences with a new anabolic steroid: 2-formyl-17(alpha)methylandrosta-1,4-dien-11(alpha)17(beta)diol-3-one].
Pardini C; Terreni F
Clin Ter; 1971 Aug; 58(4):343-50. PubMed ID: 5158278
[No Abstract] [Full Text] [Related]
12. [Clinical experience with Furazabol in mammary tumors, with special emphasis on mastopathy].
Watanuki S; Ito K; Nishikawa Y; Ajisaka H
Geka Chiryo; 1969 Apr; 20(4):470-4. PubMed ID: 5819735
[No Abstract] [Full Text] [Related]
13. [Effect of 1-alpha,-17-alpha-dimethyl androstanolone in mastopathies].
Stára B; Stĕrba R; Potuzák J
Cas Lek Cesk; 1966 Jun; 105(24):671-7. PubMed ID: 5941100
[No Abstract] [Full Text] [Related]
14. Androgen therapy.
Longson D
Practitioner; 1972 Mar; 208(245):338-48. PubMed ID: 4557109
[No Abstract] [Full Text] [Related]
15. [Therapeutic effects of furazabol, (17-beta-hydroxy-17-alpha-methyl-5-alpha-androstane [2, 3-c] furazan, on experimental atherosclerosis in rabbits].
Onodera T; Kasahara A; Ishihara M; Ogawa H; Oshima Y
Nihon Yakurigaku Zasshi; 1970 Jul; 66(4):458-69. PubMed ID: 5531414
[No Abstract] [Full Text] [Related]
16. [Clinical results of a long-acting anabolic steroid, oxynosterone cypionate (TBS) in pediatrics].
Matsumura T; Uehara Y; Ebina T
Nihon Rinsho; 1968 Dec; 26(12):3522-7. PubMed ID: 5753032
[No Abstract] [Full Text] [Related]
17. [Our experience with the treatment of mastodynia (author's transl)].
Silhán J; Cron J; Sula F; Safár A
Cesk Gynekol; 1975 Feb; 40(1):54. PubMed ID: 1131905
[No Abstract] [Full Text] [Related]
18. 2Alpha, 3alpha-epithio-5alpha-androstan-17beta-YL 1-methoxycyclopentyl ether (10364-S), a new orally active anti-estrogenic steroid.
Miyake T; Hori T; Kato G; Ide M; Uchida N; Yamaguchi K
Steroids; 1974 Jun; 23(6):929-37. PubMed ID: 4836439
[No Abstract] [Full Text] [Related]
19. [Studies of the effect of a new anabolic agent in burned patients].
Roman Calderon J
Prensa Med Mex; 1968; 33(1):51-3. PubMed ID: 5760271
[No Abstract] [Full Text] [Related]
20. [Treatment of breast and peri-mammary pain].
Juret P
Rev Fr Gynecol Obstet; 1968 Apr; 63(4):207-10. PubMed ID: 5759576
[No Abstract] [Full Text] [Related]
[Next] [New Search]
